Biomedicine
California Healthcare Institute Urges Congress to Extend R&D Tax Credit
Published in Drug Law Weekly, December 18th, 2007
The California Healthcare Institute (CHI) today urged support for congressional action to extend the federal research and development (R&D) tax credit prior to the end of this year. The credit, which will once again expire on Dec. 31, 2007, provides companies with an important incentive to make high-risk investments, leading to the development of innovative, life-saving therapies and medical technologies and contributing to job creation and economic growth.
"California's biomedical industry strongly urges Congress to act on this issue and send legislation containing a strengthened R&D tax credit to the president before the new year," said David L. Gollaher, Ph.D., CHI...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2007-12-18)
More Articles from Drug Law Weekly
- America's Second Harvest
Appropriations Veto Threats May Lead to Further Hardship for Hungry Americans - Bioinformatics
Eclipsys Chief Medical Officer Bob Elson, MD, to Present on Value of e-Prescribing at Capitol Hill Briefing - Biotechnology Business
Biovail Announces Settlement Agreement Related to Cardizem(R) LA - Biotechnology Business
David Luci Joins MacroChem as General Counsel and Vice President Corporate Development - Biotechnology Business
Watson and Biovail Settle Lawsuit Over Cardizem(R) LA - Campaign for Tobacco-Free Kids
New Report: Tobacco Regulation Would Save Utah $178 Million in Health Care Costs by Preventing 10,200 Kids From Smoking - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
